Results 61 to 70 of about 5,742,584 (242)
Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam. [PDF]
BACKGROUND\ud \ud Recently global health advocates have called for the introduction of artemisinin-containing antimalarial combination therapies to help curb the impact of drug-resistant malaria in Africa.
Catherine Goodman +7 more
core +1 more source
The recent emergence of Plasmodium falciparum parasite resistance to the first line antimalarial drug artemisinin is of particular concern. Artemisinin resistance is primarily driven by mutations in the P.
Nelson V. Simwela +5 more
doaj +1 more source
Artemisinins were discovered to be highly effective antimalarial drugs shortly after the isolation of the parent artemisinin in 1971 in China. These compounds combine potent, rapid antimalarial activity with a wide therapeutic index and an absence of ...
C J Woodrow +8 more
core +1 more source
Artemisinin resistance: Cause for worry?
Background: Artemisinin resistance is being reported from certain regions of the world. Globally, the scientific community is engaged in tracing the epidemiology of this resistance while also working on possible interventions to curb the spread.
Anurag Khera, Reema Mukherjee
doaj +1 more source
Evidence of Artemisinin-Resistant Malaria in Africa
In the six Southeast Asian countries that make up the Greater Mekong Subregion, Plasmodium falciparum has developed resistance to derivatives of artemisinin, the main component of first-line treatments for malaria. Clinical resistance to artemisinin monotherapy in other global regions, including Africa, would be problematic.In this longitudinal study ...
Betty Balikagala +14 more
openaire +3 more sources
The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in rural Tanzania. [PDF]
BACKGROUND\ud \ud The development of antimalarial drug resistance has led to increasing calls for the introduction of artemisinin-based combination therapy (ACT).
Goodman Catherine A +17 more
core +1 more source
Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites.
Due to their remarkable parasitocidal activity, artemisinins represent the key components of first-line therapies against Plasmodium falciparum malaria. However, the decline in efficacy of artemisinin-based drugs jeopardizes global efforts to control and
Frances Rocamora +6 more
doaj +1 more source
Current best practice for the treatment of malaria relies on short half-life artemisinins that are failing against emerging Kelch 13 mutant parasite strains.
Yawei Du +9 more
semanticscholar +1 more source
In vivo parasitological measures of artemisinin susceptibility [PDF]
Parasite clearance data from 18,699 patients with falciparum malaria treated with an artemisinin derivative in areas of low (n=14,539), moderate (n=2077), and high (n=2083) levels of malaria transmission across the world were analyzed to determine the ...
Smithuis, F +75 more
core +1 more source
Molecular Evidence of Drug Resistance in Asymptomatic Malaria Infections, Myanmar, 2015
Artemisinin resistance containment in Myanmar was initiated in 2011 after artemisinin-resistant Plasmodium falciparum malaria was reported. Molecular evidence suggests that asymptomatic malaria infections harboring drug resistance genes are present among
Myat Htut Nyunt +9 more
doaj +1 more source

